{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:53:01Z","timestamp":1782931981361,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11596-024-2915-x","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T05:02:07Z","timestamp":1722661327000},"page":"680-685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Research Progress on the Pathogenesis and Treatment of Neoatherosclerosis"],"prefix":"10.1007","volume":"44","author":[{"given":"Yi-shan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-miao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,3]]},"reference":[{"issue":"2","key":"2915_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrcardio.2015.164","volume":"13","author":"K Yahagi","year":"2016","unstructured":"Yahagi K, Kolodgie FD, Otsuka F, et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat Rev Cardiol, 2016,13(2):79\u201398","journal-title":"Nat Rev Cardiol"},{"key":"2915_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.thromres.2019.03.016","volume":"178","author":"I Mazin","year":"2019","unstructured":"Mazin I, Paul G, Asher E, et al. Neoatherosclerosis - From basic concept to clinical implication. Thromb Res, 2019,178:12\u201316","journal-title":"Thromb Res"},{"issue":"2","key":"2915_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/ehjcvp\/pvy036","volume":"5","author":"JA Borovac","year":"2019","unstructured":"Borovac JA, D\u2019Amario D, Vergallo R, et al. Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge. Eur Heart J Cardiovasc Pharmacother, 2019,5(2):105\u2013116","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"1","key":"2915_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/clinchem\/hvaa275","volume":"67","author":"P Libby","year":"2021","unstructured":"Libby P. Inflammation in Atherosclerosis\u2014No Longer a Theory. Clin Chem, 2021,67(1):131\u2013142","journal-title":"Clin Chem"},{"issue":"4","key":"2915_CR5","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3390\/cells10040951","volume":"10","author":"P Libby","year":"2021","unstructured":"Libby P. Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond. Cells, 2021,10(4):951","journal-title":"Cells"},{"key":"2915_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.atherosclerosis.2018.07.014","volume":"276","author":"P Raggi","year":"2018","unstructured":"Raggi P, Genest J, Giles JT, et al. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis, 2018,276:98\u2013108","journal-title":"Atherosclerosis"},{"issue":"7347","key":"2915_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature10146","volume":"473","author":"P Libby","year":"2011","unstructured":"Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature, 2011,473(7347):317\u2013325","journal-title":"Nature"},{"issue":"9","key":"2915_CR8","doi-asserted-by":"publisher","first-page":"e011693","DOI":"10.1161\/CIRCINTERVENTIONS.121.011693","volume":"15","author":"ZY Chen","year":"2022","unstructured":"Chen ZY, Matsumura M, Mintz GS, et al. Prevalence and Impact of Neoatherosclerosis on Clinical Outcomes After Percutaneous Treatment of Second-Generation Drug-Eluting Stent Restenosis. Circ Cardiovasc Interv, 2022,15(9):e011693","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"2915_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, et al. 2019 ESC\/EAS Guidelines for the management of dyslipidemias: lipid modification to reduce cardiovascular risk. Eur Heart J, 2020,41(1):111\u2013188","journal-title":"Eur Heart J"},{"issue":"10","key":"2915_CR10","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jcin.2011.06.016","volume":"4","author":"L Raber","year":"2011","unstructured":"Raber L, Serruys PW. Late vascular response following drug-eluting stent implantation. JACC Cardiovasc Interv, 2011,4(10):1075\u20131078","journal-title":"JACC Cardiovasc Interv"},{"issue":"19","key":"2915_CR11","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1161\/CIRCULATIONAHA.116.025129","volume":"134","author":"I Andreou","year":"2016","unstructured":"Andreou I, Stone PH. In-Stent Atherosclerosis at a Crossroads: Neoatherosclerosis or Paleoatherosclerosis? Circulation, 2016, 134(19):1413\u20131415","journal-title":"Circulation"},{"issue":"8","key":"2915_CR12","doi-asserted-by":"publisher","first-page":"e19073","DOI":"10.1016\/j.heliyon.2023.e19073","volume":"9","author":"X Yuan","year":"2023","unstructured":"Yuan X, Jiang M, Feng H, et al. The effect of sex differences on neointimal characteristics of in-stent restenosis in drug-eluting stents: An optical coherence tomography study. Heliyon, 2023,9(8):e19073","journal-title":"Heliyon"},{"issue":"6","key":"2915_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.4244\/EIJ-D-20-00539","volume":"17","author":"D Nakamura","year":"2021","unstructured":"Nakamura D, Dohi T, Ishihara T, et al. Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis. EuroIntervention, 2021,17(6):489\u2013496","journal-title":"EuroIntervention"},{"issue":"2","key":"2915_CR14","doi-asserted-by":"publisher","first-page":"e001878","DOI":"10.1161\/CIRCINTERVENTIONS.114.001878","volume":"8","author":"SY Lee","year":"2015","unstructured":"Lee SY, Hur SH, Lee SG, et al. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation. Circ Cardiovasc Interv, 2015,8(2):e001878","journal-title":"Circ Cardiovasc Interv"},{"key":"2915_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijcard.2018.06.065","volume":"272","author":"R Torii","year":"2018","unstructured":"Torii R, Stettler R, Raber L, et al. Implications of the local hemodynamic forces on the formation and destabilization of neoatherosclerotic lesions. Int J Cardiol, 2018,272:7\u201312","journal-title":"Int J Cardiol"},{"issue":"1","key":"2915_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41569-019-0234-x","volume":"17","author":"S Torii","year":"2020","unstructured":"Torii S, Jinnouchi H, Sakamoto A, et al. Drug-eluting coronary stents: insights from preclinical and pathology studies. Nat Rev Cardiol, 2020,17(1):37\u201351","journal-title":"Nat Rev Cardiol"},{"issue":"32","key":"2915_CR17","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1093\/eurheartj\/ehv205","volume":"36","author":"F Otsuka","year":"2015","unstructured":"Otsuka F, Byrne RA, Yahagi K, et al. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J, 2015,36(32):2147\u20132159","journal-title":"Eur Heart J"},{"issue":"11","key":"2915_CR18","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","volume":"57","author":"G Nakazawa","year":"2011","unstructured":"Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol, 2011,57(11):1314\u20131322","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2915_CR19","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/01.CIR.0000159354.43778.69","volume":"111","author":"IK Jang","year":"2005","unstructured":"Jang IK, Tearney GJ, MacNeill B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation, 2005,111(12):1551\u20131555","journal-title":"Circulation"},{"issue":"9","key":"2915_CR20","doi-asserted-by":"publisher","first-page":"e003785","DOI":"10.1161\/CIRCINTERVENTIONS.116.003785","volume":"9","author":"D Nakamura","year":"2016","unstructured":"Nakamura D, Attizzani GF, Toma C, et al. Failure Mechanisms and Neoatherosclerosis Patterns in Very Late Drug-Eluting and Bare-Metal Stent Thrombosis. Circ Cardiovasc Interv, 2016,9(9):e003785","journal-title":"Circ Cardiovasc Interv"},{"issue":"13","key":"2915_CR21","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/01.CIR.0000029927.92825.F6","volume":"106","author":"H Yabushita","year":"2002","unstructured":"Yabushita H, Bouma BE, Houser SL, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation, 2002,106(13):1640\u20131645","journal-title":"Circulation"},{"issue":"5","key":"2915_CR22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1161\/CIRCINTERVENTIONS.112.000248","volume":"6","author":"ZA Ali","year":"2013","unstructured":"Ali ZA, Roleder T, Narula J, et al. Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents. Circ Cardiovasc Interv, 2013,6(5):507\u2013517","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"2915_CR23","first-page":"393","volume":"12","author":"A Nusca","year":"2022","unstructured":"Nusca A, Viscusi MM, Piccirillo F, et al. In Stent Neoatherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches. Life (Basel), 2022,12(3):393","journal-title":"Life (Basel)"},{"issue":"23","key":"2915_CR24","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/j.jacc.2011.10.909","volume":"59","author":"SJ Park","year":"2012","unstructured":"Park SJ, Kang SJ, Virmani R, et al. In-stent neoatherosclerosis: a final common pathway of late stent failure. J Am Coll Cardiol, 2012,59(23):2051\u20132057","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2915_CR25","first-page":"463","volume":"90","author":"JA Borovac","year":"2017","unstructured":"Borovac JA, D\u2019Amario D, Niccoli G. Neoatherosclerosis and Late Thrombosis After Percutaneous Coronary Intervention: Translational Cardiology and Comparative Medicine from Bench to Bedside. Yale J Biol Med, 2017,90(3):463\u2013470","journal-title":"Yale J Biol Med"},{"issue":"5","key":"2915_CR26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jcmg.2009.01.011","volume":"2","author":"G Nakazawa","year":"2009","unstructured":"Nakazawa G, Vorpahl M, Finn AV, et al. One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. JACC Cardiovasc Imaging, 2009,2(5):625\u2013628","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"2915_CR27","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.4158\/CS-2020-0490","volume":"26","author":"Y Handelsman","year":"2020","unstructured":"Handelsman Y, Jellinger PS, Guerin CK, et al. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary. Endocr Pract, 2020,26(10):1196\u20131224","journal-title":"Endocr Pract"},{"issue":"8","key":"2915_CR28","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1161\/01.CIR.0000139337.56084.30","volume":"110","author":"A Farb","year":"2004","unstructured":"Farb A, Kolodgie FD, Hwang JY, et al. Extracellular matrix changes in stented human coronary arteries. Circulation, 2004,110(8):940\u2013947","journal-title":"Circulation"},{"issue":"6","key":"2915_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jjcc.2014.03.001","volume":"64","author":"T Araki","year":"2014","unstructured":"Araki T, Nakamura M, Sugi K. Characterization of in-stent neointimal tissue components following drug-eluting stent implantation according to the phase of restenosis using a 40-MHz intravascular ultrasound imaging system. J Cardiol, 2014,64(6):423\u2013429","journal-title":"J Cardiol"},{"key":"2915_CR30","doi-asserted-by":"publisher","first-page":"5924234","DOI":"10.1155\/2016\/5924234","volume":"2016","author":"Y Cui","year":"2016","unstructured":"Cui Y, Liu Y, Zhao F, et al. Neoatherosclerosis after Drug-Eluting Stent Implantation: Roles and Mechanisms. Oxid Med Cell Longev, 2016,2016:5924234","journal-title":"Oxid Med Cell Longev"},{"key":"2915_CR31","doi-asserted-by":"publisher","first-page":"1025858","DOI":"10.3389\/fcvm.2022.1025858","volume":"9","author":"H Wang","year":"2022","unstructured":"Wang H, Wang Q, Hu J, et al. Global research trends in in-stent neoatherosclerosis: A CiteSpace-based visual analysis. Front Cardiovasc Med, 2022,9:1025858","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2915_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s10020-022-00450-3","volume":"28","author":"ZW Wang","year":"2022","unstructured":"Wang ZW, Chen J, Zeng ZL, et al. The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation. Mol Med, 2022,28(1):26","journal-title":"Mol Med"},{"issue":"16","key":"2915_CR33","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.7150\/ijms.63065","volume":"18","author":"ZW Wang","year":"2021","unstructured":"Wang ZW, Guo XP, Zhang Q, et al. Elimination of Ox-LDL through the liver inhibits advanced atherosclerotic plaque progression. Int J Med Sci, 2021,18(16):3652\u20133664","journal-title":"Int J Med Sci"},{"issue":"8","key":"2915_CR34","doi-asserted-by":"publisher","first-page":"166805","DOI":"10.1016\/j.bbadis.2023.166805","volume":"1869","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Du GH, Tong L, et al. Overexpression of LOX-1 in hepatocytes protects vascular smooth muscle cells from phenotype transformation and wire injury induced carotid neoatherosclerosis through ALOX15. Biochim Biophys Acta Mol Basis Dis, 2023,1869(8):166805","journal-title":"Biochim Biophys Acta Mol Basis Dis"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2915-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-024-2915-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2915-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T22:14:02Z","timestamp":1733868842000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-024-2915-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["2915"],"URL":"https:\/\/doi.org\/10.1007\/s11596-024-2915-x","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"8 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}